Taylor et al. suggested that using cancer-specific EVs, such as EpCAM-positive or GPC1-positive EVs, could help overcome the limitation and improve the diagnostic efficiency for CRC [76, 77].In the current review, EV proteins revealed superior diagnostic performance for CRC, with summarized diagnostic values that were higher than EV RNAs. This evidence concerns the gene GPC1 and colorectal carcinoma.